المؤلفون: Onishi A, Matsumura-Kimoto Y, Mizutani S, Tsukamoto T, Fujino T, Miyashita A, Nishiyama D, Shimura K, Kaneko H, Kawata E, Takahashi R, Kobayashi T, Uchiyama H, Uoshima N, Nukui Y, Shimura Y, Inaba T, Kuroda J

المصدر: Infection and Drug Resistance, Vol Volume 16, Pp 509-519 (2023)

مصطلحات موضوعية: covid-19, vaccine, b-cell lymphoma, anti-cd20 monoclonal antibody, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://www.dovepress.com/impact-of-treatment-with-anti-cd20-monoclonal-antibody-on-the-producti-peer-reviewed-fulltext-article-IDR; https://doaj.org/toc/1178-6973

URL الوصول: https://doaj.org/article/78f3221619794f469499ce032a0b7b49

المؤلفون: Ide D; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Egashira A; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Mizuhara K; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Uchiyama H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Kaneko H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Kawata E; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan., Taniwaki M; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Blood Transfusion, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. junkuro@koto.kpu-m.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 697-706. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/therapy , Lymphoma, Large B-Cell, Diffuse*/blood , Lymphoma, Large B-Cell, Diffuse*/diagnosis , Lymphoma, Large B-Cell, Diffuse*/mortality , Monocytes* , Lymphocytes*/pathology, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Middle Aged ; Prognosis ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/therapeutic use ; Rituximab/administration & dosage ; Rituximab/therapeutic use ; Doxorubicin/administration & dosage ; Doxorubicin/therapeutic use ; Recurrence ; Prednisone/administration & dosage ; Prednisone/therapeutic use ; Adult ; Vincristine/administration & dosage ; Vincristine/therapeutic use

المؤلفون: Shimazu Y; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kyoto, Kawaramachi, Shogoin, Sakyoku, 606-8507, Japan.; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy, Kyoto University Hospital, Kyoto, Japan.; Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kanda J; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kyoto, Kawaramachi, Shogoin, Sakyoku, 606-8507, Japan. jkanda16@kuhp.kyoto-u.ac.jp., Onda Y; Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan., Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Ohta K; Hematology Ohta Clinic, Shinsaibashi, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kosugi S; Department of Hematology, Toyonaka Municipal Hospital, Toyonaka, Japan., Yamamura R; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan., Matsuda M; Department of Hematology, PL General Hospital, Osaka, Japan., Hanamoto H; Department of Hematology, Kindai University Nara Hospital, Ikoma, Japan., Adachi Y; Department of Internal Medicine, Japan Community Health Care Organization Kobe Central Hospital, Kyoto, Japan., Anzai N; Department of Hematology, Uji Tokushukai Hospital, Uji, Japan., Hotta M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Yagi H; Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan., Yoshihara S; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan., Tanaka Y; Department of Hematology, Shinko Hospital, Kobe, Japan., Takakuwa T; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Tanaka H; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Higashiosaka, Japan., Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Higashiosaka, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Takaori-Kondo A; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, 54, Kyoto, Kawaramachi, Shogoin, Sakyoku, 606-8507, Japan., Hino M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 May 17; Vol. 73 (7), pp. 135. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/mortality , Thalidomide*/analogs & derivatives , Thalidomide*/therapeutic use , Thalidomide*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Lymphocytes* , Monocytes*/immunology , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage, Humans ; Female ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Adult ; Aged, 80 and over ; Prognosis

المؤلفون: Ogata M; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Hasama-Machi, Yufu, Oita, 879-5593, Japan. mogata@oita-u.ac.jp.; Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University, Oita, Japan. mogata@oita-u.ac.jp., Oshima K; Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan., Takano K; Department of Hematology, Oita University Hospital, Oita, Japan., Kawano R; Department of Hematology, Oita University Hospital, Oita, Japan., Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Okayama, Japan., Imamura T; Department of Clinical Psychology, Kurashiki Central Hospital, Okayama, Japan., Nakamura Y; Third Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan., Okada T; Department of Hematology, Shimane University Hospital, Shimane, Japan., Toubai T; Division of Hematology and Cell Therapy, Department of Internal Medicine III, Faculty of Medicine, Yamagata University, Yamagata, Japan., Ueki T; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Ishida H; Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan., Shinohara A; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan., Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Inagaki M; Department of Psychiatry, Faculty of Medicine, Shimane University, Shimane, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 Apr; Vol. 119 (4), pp. 432-441. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Herpesvirus 6, Human*/genetics , Cord Blood Stem Cell Transplantation*/adverse effects , Delirium* , Hematopoietic Stem Cell Transplantation*, Humans ; Quality of Life ; Prospective Studies ; Virus Activation ; DNA, Viral ; Cognition

المؤلفون: Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Lee JW; Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea., Jang JH; Department of Hematology, Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea., Tomiyama Y; Department of Blood Transfusion, Osaka University Hospital, Osaka, Japan., Miyazaki K; Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine, Sagamihara, Japan., Nagafuji K; Department of Hematology, Kurume University Hospital, Kurume, Japan., Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Fujisaki T; Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan., Kosugi H; Department of Hematology, Ogaki Municipal Hospital, Ogaki, Japan., Matsumura I; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Sasaki K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Kobayashi N; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan., Ichikawa S; Department of Hematology, Tohoku University Hospital, Sendai, Japan., Yonemura Y; Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital, Kumamoto, Japan., Murotani K; Biostatistics Center, Kurume University, Kurume, Japan., Shimizu M; Department of Medical Affairs, Kyowa Kirin Co, Ltd, Tokyo, Japan., Matsuda A; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama Medical University, Saitama, Japan., Ozawa K; Division of Hematology, Jichi Medical University, Tochigi, Japan., Nakao S; Division of Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

المصدر: Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1415-1419.

نوع المنشور: Clinical Trial, Phase III; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/drug therapy , Receptors, Fc*, Humans ; Follow-Up Studies ; Recombinant Fusion Proteins/adverse effects ; Thrombopoietin/adverse effects

المؤلفون: Nakamura N; Department of Hematology, Shinko Hospital, 1-4-47, Wakihamacho, Chuo-Ku, Kobe, Hyogo, 651-0072, Japan. n_nakamura@kuhp.kyoto-u.ac.jp.; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan. n_nakamura@kuhp.kyoto-u.ac.jp., Arima N; Department of Hematology, Shinko Hospital, 1-4-47, Wakihamacho, Chuo-Ku, Kobe, Hyogo, 651-0072, Japan., Takakuwa T; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Yoshioka S; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan., Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan., Fukushima K; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan., Hotta M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Kanda J; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Tanaka H; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan., Ohta K; Hematology Ohta Clinic, Shinsaibashi, Japan., Kosugi S; Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Toyonaka, Japan., Yagi H; Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan., Yoshihara S; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan., Yamamura R; Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Nakatsu, Japan., Adachi Y; Department of Internal Medicine, JCHO Kobe Central Hospital, Kobe, Japan., Hanamoto H; Department of Hematology, Kindai University Nara Hospital, Nara, Japan., Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan., Ito T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan., Shimazaki C; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Takaori-Kondo A; Department of Hematology and Oncology Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan., Hino M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

مؤلفون مشاركون: Kansai Myeloma Forum

المصدر: Annals of hematology [Ann Hematol] 2024 Mar 16. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

المؤلفون: Hidaka M; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Inokuchi K; Department of Hematology, Nippon Medical School, Tokyo, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Takahashi N; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan., Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Aichi, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan., Nakamae H; Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan., Iwasaki H; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan., Watanabe K; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan., Kosaka Y; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan., Komatsu N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Meguro K; Department of Hematology, National Hospital Organization Sendai Medical Center, Miyagi, Japan., Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Kondo T; Blood Disorders Center, Aiiku Hospital, Hokkaido, Japan., Kimura S; Department of Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan., Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan., Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Aichi, Japan., Hata T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan., Horibe K; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Aichi, Japan., Iida H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan., Shimomura T; Department of Hematology, National Hospital Organization Hiroshimanishi Medical Center, Hiroshima, Japan., Dobashi N; Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, Tokyo, Japan., Sugiura I; Department of Hematology and Oncology, Toyohashi Municipal Hospital, Aichi, Japan., Makiyama J; Department of Hematology/Oncology, Institute of Medical Science, The University of Tokyo Hospital, Tokyo, Japan., Miyagawa N; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan., Sato A; Diagnostic Division, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan., Ito R; Diagnostic Division, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan., Matsumura I; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Kanakura Y; Sumitomo Hospital, Osaka, Japan., Naoe T; National Hospital Organization Nagoya Medical Center, Aichi, Japan.

المصدر: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2024 Feb 07; Vol. 54 (2), pp. 153-159.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Philadelphia Chromosome* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Adult ; Child ; Humans ; Fusion Proteins, bcr-abl/analysis ; Fusion Proteins, bcr-abl/genetics ; Real-Time Polymerase Chain Reaction ; RNA

المؤلفون: Onishi A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Matsumura-Kimoto Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Isa R; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan.; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Okumura K; Faculty of Clinical Laboratory, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan., Nishiyama D; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan., Hirakawa K; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan., Shimura K; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Kaneko H; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan., Kiyota M; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan., Kawata E; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan., Takahashi R; Department of Hematology, Omihachiman Community Medical Center, Omihachiman, Japan., Kobayashi T; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Nukui Y; Division of Infection Control & Molecular Laboratory Medicine, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan., Inaba T; Faculty of Clinical Laboratory, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Division of Infection Control & Molecular Laboratory Medicine, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kamigyo-Ku, Kyoto, 602-8566, Japan. junkuro@koto.kpu-m.ac.jp.

مؤلفون مشاركون: Kyoto Clinical Hematology Study Group investigators

المصدر: International journal of hematology [Int J Hematol] 2024 Jan; Vol. 119 (1), pp. 50-61. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , COVID-19*/prevention & control, Humans ; SARS-CoV-2 ; Vaccination ; Antibodies, Viral ; COVID-19 Vaccines ; Immunoglobulin M ; RNA, Messenger

المؤلفون: Inoue Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Okamoto H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Miyashita A; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Kawaji-Kanayama Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Chinen S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Tsukamoto T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan., Kaneko H; Department of Hematology, Aiseikai Yamashina Hospital, Kyoto 607-8086, Japan., Kuwahara-Ota S; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto 603-8151, Japan., Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto 603-8151, Japan., Nishiyama D; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Kyoto 620-0056, Japan., Hirakawa K; Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Kyoto 620-0056, Japan., Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 605-0981, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto 602-8031, Japan., Kawata E; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Osaka 570-8540, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.

المصدر: Oncology letters [Oncol Lett] 2023 Dec 18; Vol. 27 (2), pp. 62. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE

المؤلفون: Takeda, J, Iwasaki, M, Kanda, J, Nannya, Y, Hiramoto, N, Kondo, T, Ishikawa, T, Watanabe, M, Kawata, T, Maeda, T, Ueda, Y, Imada, K, Kitano, T, Tsuji, M, Maesako, Y, Oka, S, Tanaka, Y, Miyoshi, T, Asagoe, K, Itoh, M, Hirata, H, Kawabata, H, Hishizawa, M, Maeda, A, Yago, K, Sasaki, N, Uoshima, N, Ogawa, S, Takaori-Kondo, A

المصدر: BLOOD. 142

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154974404